LGALS3 and COVID-19: (29) study defined a composite endpoint of admission to ICU or 30-day mortality and found that COVID-19 cases with a composite endpoint had significantly higher levels of Gal-3 (12.1 [10.3-15.9] ng/ml vs. 8.1[6.5-11.3] ng/ml, P < 0.001).